| Date Filed | Type | Description |
| 08/10/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/24/2023 |
8-K
| Quarterly results |
| 07/14/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 07/10/2023 |
S-3/A
| Form S-3/A - Registration statement under Securities Act of 1933: [Amend] |
| 06/29/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 06/07/2023 |
SD
| Form SD - Specialized disclosure report: |
| 05/16/2023 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/09/2023 |
8-K/A
| Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Ob... |
| 05/08/2023 |
4
| Matheis Dennis (Director) has filed a Form 4 on DarioHealth Corp.|
Txns:
| Bought 50 preferred shares
@ $3.37, valued at
$168.5 |
|
| 05/08/2023 |
4
| Shaked Yoav (Director) has filed a Form 4 on DarioHealth Corp.|
Txns:
| Bought 40 preferred shares
@ $3.37, valued at
$134.8 |
|
| 05/08/2023 |
4
| KAPLAN JON H. (Director) has filed a Form 4 on DarioHealth Corp.|
Txns:
| Bought 30 preferred shares
@ $3.37, valued at
$101.1 |
|
| 05/08/2023 |
4
| Raphael Erez (CEO) has filed a Form 4 on DarioHealth Corp.|
Txns:
| Bought 30 preferred shares
@ $3.37, valued at
$101.1 |
|
| 05/05/2023 |
8-K
| Quarterly results |
| 03/09/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/24/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/14/2023 |
SC 13G/A
| Nantahala Capital Management, LLC reports a 9.9% stake in DarioHealth Corp. |
| 02/14/2023 |
SC 13G/A
| Phoenix Holdings Ltd. reports a 5.2% stake in DarioHealth Corp. |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/06/2023 |
8-K
| Results of Operations and Financial Condition, Triggering Events That Accelerate or Increase a Direct Financial Obligation or... |
| 01/27/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2023 |
8-K
| Other Events Interactive Data |
| 01/13/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 01/06/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 12/30/2022 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 12/23/2022 |
4
| MCGRATH DENNIS M (Director) has filed a Form 4 on DarioHealth Corp.|
Txns:
| Sold 9,872 shares
@ $3.9714, valued at
$39.2k
|
|
| 12/07/2022 |
8-K
| Quarterly results |
| 11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 10/14/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 10/03/2022 |
8-K
| Shareholder Nominations Pursuant to Exchange Act Rule 14a-11 Interactive Data |
| 08/15/2022 |
8-K
| Quarterly results |
|